DMedical Limited (ASX: 4DX), the global leader in advanced respiratory imaging, today announced that CT:VQ™ technology has ...
Medicare confirms reimbursement, unlocking nationwide access to non-contrast ventilation–perfusion imaging from routine chest CT LOS ANGELES, Sept. 4, 2025 /PRNewswire/ -- 4DMedical, a leader in ...
Thank you for standing by, and welcome to the 4DMedical Investor Webinar. I would now like to hand the conference over to John Hester, Senior Analyst at Bell Potter. Please go ahead. Thank you. Thank ...
Hey everybody. Really, thank you so much for joining this call. I'm incredibly appreciative of your interest. I hope you can bear with me. My voice is pretty hoarse. I've literally had hundreds and ...
Capital Brief on MSN
4D Medical shares fall despite winning Australian regulatory approval
More news: Shares in 4D Medical tumbled in afternoon trade despite the lung imaging company clearing its final regulatory ...
It all started in August when the lung scanning innovator inked a deal with the giant ASX-listed Pro Medicus, involving a $10 million loan and the hint of other liaisons to come. On September 1, 4D ...
Non-contrast, ventilation-perfusion imaging-from routine chest CT scansMELBOURNE, Australia, June 29, 2026 /PRNewswire/ -- 4DMedical Limited (ASX: 4DX), the global leader in advanced respiratory ...
LOS ANGELES, Sept. 4, 2025 /PRNewswire/ -- 4DMedical, a leader in advanced respiratory imaging, today announces U.S. Food and Drug Administration (FDA) 510(k) clearance for CT:VQ™, the world's first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results